CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-05 | Jovan-Embiricos Morana Director | Sale | −7,124 | $24.80 | $177K | 1,379,185 |
| 2021-11-05 | Jovan-Embiricos Morana Director | Sale | −1,257 | $24.80 | $31K | 343,385 |
| 2021-10-27 | Jovan-Embiricos Morana Director | Sale | −1,870 | $24.78 | $46K | 1,386,309 |
| 2021-10-27 | Jovan-Embiricos Morana Director | Sale | −330 | $24.78 | $8K | 344,642 |
| 2021-10-25 | Jovan-Embiricos Morana Director | Sale | −6,604 | $24.82 | $164K | 1,388,179 |
| 2021-10-25 | Jovan-Embiricos Morana Director | Sale | −1,165 | $24.82 | $29K | 344,972 |
| 2021-10-22 | Jovan-Embiricos Morana Director | Sale | −4,864 | $24.77 | $120K | 1,394,783 |
| 2021-10-22 | Jovan-Embiricos Morana Director | Sale | −859 | $24.77 | $21K | 346,137 |
| 2021-10-21 | Jovan-Embiricos Morana Director | Sale | −85 | $24.75 | $2K | 1,399,647 |
| 2021-10-21 | Jovan-Embiricos Morana Director | Sale | −15 | $24.75 | $371 | 346,996 |
| 2021-10-21 | Atillasoy Ercem | Sale | −1,514 | $24.23 | $37K | 104,986 |
| 2021-10-04 | Melian Agustin Chief Medical Officer | Sale | −10,678 | $23.29 | $249K | 461,540 |
| 2021-10-04 | Melian Agustin Chief Medical Officer | Sale | −4,711 | $24.23 | $114K | 456,829 |
| 2021-10-04 | Melian Agustin Chief Medical Officer | Sale | −2,967 | $25.41 | $75K | 453,862 |
| 2021-10-04 | Melian Agustin Chief Medical Officer | Sale | −333 | $26.02 | $9K | 453,529 |
| 2021-10-01 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −3,413 | $25.07 | $86K | 418,595 |
| 2021-09-30 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −12,171 | $25.17 | $306K | 422,008 |
| 2021-09-29 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −1,000 | $25.04 | $25K | 434,179 |
| 2021-09-28 | Melian Agustin Chief Medical Officer | Sale | −3,750 | $24.12 | $90K | 472,218 |
| 2021-09-17 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −5,916 | $25.08 | $148K | 435,179 |
Page 17 of 27 · 527 trades